Notícias Eulerpool Intellia Therapeutics

Intellia Therapeutics Notícias de ações

Intellia Therapeutics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Intellia Therapeutics nós reunimos aqui.

• 25 de janeiro ·

  SeekingAlpha
  Undercovered Dozen: Virgin Galactic, Gold Fields, Matador Resources, EHang +
• 17 de janeiro ·

  SeekingAlpha
  Editas And Intellia: Strategic Shifts And Long-Term Investment Potential
• 14 de janeiro ·

  SeekingAlpha
  Intellia Therapeutics Disappointed Investors Again On January 9 (Rating Downgrade)
• 13 de janeiro ·

  SeekingAlpha
  Intellia Therapeutics: Buying The Path To Commercialization
• 10 de janeiro ·

  Yahoo
  NTLA Announces Strategic Reorganization & Job Cuts in 2025, Stock Down
• 10 de janeiro ·

  Yahoo
  Intellia to stop work on rare disease therapy, lay off staff
• 9 de janeiro ·

  Yahoo
  Intellia Therapeutics Announces Anticipated 2025 Milestones and Strategic Reorganization to Prioritize the Advancement of its Late-Stage Programs, NTLA-2002 and Nexiguran Ziclumeran (nex-z)
• 8 de janeiro ·

  SeekingAlpha
  2024 Performance Review And Future Strategy
• 6 de janeiro ·

  Yahoo
  Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• 30 de dezembro ·

  Yahoo
  Why Is Intellia Therapeutics, Inc. (NTLA) Among the Top CRISPR Stocks to Invest In?